BioSpace News Archive

Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today that it has priced an underwritten registered offering of 7,250,000 shares of its Class 2 common stock and, in lieu of Class 2 common stock

ARDS Foundation, a nonprofit organization dedicated to supporting patients and families faced with the horrific diagnosis of Acute Respiratory Distress Syndrome (ARDS), announced today it will host a live webinar on Monday, March 16, 2020, from 11:30 a.m. to 12:30 p.m.

Research well underway as Janssen scientists collaborate with leading virology laboratory led by Dan Barouch, M.D., Ph.D.

Analytics for Risk Contracting (ARC), LLC, a SAAS platform that enables health care providers to determine their actual total cost of care and understand the net financial effect of specific care improvement, population health management and other quality and cost initiatives, has added Sendero Health Plans to their portfolio of clients

Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of its latest go-to-market strategy engagement for a pharma company.

Fungi Perfecti, LLC (makers of Host Defense® Mushrooms™) partnered with the third-party experts at Natural Immune Systems, Inc to publish a new, peer-reviewed manuscript in the highly respected international, open-access Journal of Inflammation Research.

On March 12, 2020 , the U.S. Food and Drug Administration (FDA) issued a safety alert regarding the use of fecal microbiota for transplantation (FMT) due to infections caused by enteropathogenic Escherichia coli (EPEC) and Shigatoxin-producing Escherichia coli (STEC). https://www.fda.gov/vaccines-blood-biologics/safety-availab

Sodexo today announced that it will ensure sick pay for all employees, either full time or part time, for up to 21 workdays if they have a confirmed case of COVID-19 or are asked not to come to work for COVID-19 related symptoms.

As the global community continues its fight to contain the 2019 Novel Coronavirus (COVID-19) pandemic, SC Johnson today announced a $1 million contribution to the CDC Foundation’s Emergency Response Fund to strengthen domestic and global public health infrastructure and responses to address the spread of COVID-19.

Toxys is an innovative Dutch biotech company that develops unique animal-free laboratory tests for the safety assessment of novel medicines, chemicals, cosmetics and food. Today, Toxys announces a €2 million funding round from KIKK Capital, InnovationQuarter, Zeeland Investment fund, Toxys management and Rabobank.